Literature DB >> 20523051

Validity and reliability of the Persian language version of the neuropsychiatry unit cognitive assessment tool.

M Barekatain1, M Walterfang, M Behdad, M Tavakkoli, J Mahvari, M R Maracy, D Velakoulis.   

Abstract

BACKGROUND/AIMS: Only a limited number of cognitive screening tools are available for the Persian-speaking population, and we sought to translate and validate the Neuropsychiatry Unit Cognitive Assessment Tool (NUCOG), a multidimensional cognitive screening tool.
METHODS: We used multiple language specialists to translate and then back-translate the NUCOG, and administered the Persian language NUCOG and Mini-Mental State Examination (MMSE) to 184 individuals: 60 controls and 124 patients, 33 of whom had dementia, 30 non-dementing neurological disorders and 61 a psychiatric illness.
RESULTS: The NUCOG outperformed the MMSE in differentiating the patient groups and controls. The 'profile' across the 5 NUCOG domains differentiated dementia subgroups such as senile dementia of the Alzheimer type (SDAT), frontotemporal dementia and mild cognitive impairment (MCI). Psychiatric patients with psychosis and posttraumatic stress disorder were more impaired than patients with affective disorders. The NUCOG reliably differentiated controls from patients with MCI (at 86.5/100, sensitivity of 83.3% and specificity of 87.5%) and SDAT (at 75/100, sensitivity and specificity of 100%) patients from controls.
CONCLUSIONS: The Persian language NUCOG appears to perform strongly in an unselected population, reliably differentiating patients with dementia from controls, and detecting cognitive impairment in a range of clinical disorders. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20523051     DOI: 10.1159/000313981

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  6 in total

1.  The relationship between regional brain volumes and the extent of coronary artery disease in mild cognitive impairment.

Authors:  Majid Barekatain; Hedyeh Askarpour; Faezeh Zahedian; Mark Walterfang; Dennis Velakoulis; Mohammad Reza Maracy; Mohammad Hashemi Jazi
Journal:  J Res Med Sci       Date:  2014-08       Impact factor: 1.852

2.  Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment.

Authors:  Majid Barekatain; Faezeh Zahedian; Hedyeh Askarpour; Mohammad Reza Maracy; Mohammad Hashemi-Jazi; Mohammad Reza Aghaye-Ghazvini
Journal:  ARYA Atheroscler       Date:  2014-09

3.  Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II).

Authors:  Gita Shafiee; Afshin Ostovar; Ramin Heshmat; Hossein Darabi; Farshad Sharifi; Alireza Raeisi; Neda Mehrdad; Zhaleh Shadman; Faride Razi; Mohammad Reza Amini; Seyed Masoud Arzaghi; Hamidreza Aghaei Meybodi; Akbar Soltani; Iraj Nabipour; Bagher Larijani
Journal:  BMJ Open       Date:  2017-08-04       Impact factor: 2.692

4.  Cognitive rehabilitation in patients with nonamnestic mild cognitive impairment.

Authors:  Majid Barekatain; Maryam Alavirad; Mahgol Tavakoli; Golita Emsaki; Mohammad Reza Maracy
Journal:  J Res Med Sci       Date:  2016-11-02       Impact factor: 1.852

5.  Hippocampal volume and hippocampal angle (a more practical marker) in mild cognitive impairment: A case-control magnetic resonance imaging study.

Authors:  Reza Basiratnia; Ehsan Amini; Mohammad Reza Sharbafchi; Mohammad Maracy; Majid Barekatain
Journal:  Adv Biomed Res       Date:  2015-09-28

6.  Comparison of Design Fluency Test Results among Patients with Parkinson's Disease, Frontotemporal Dementia, and the Control Group.

Authors:  Majid Barekatain; Fatemeh Rajabi; Amrollah Ebrahimi; Mohammad Reza Maracy; Sahar Akbaripour
Journal:  Adv Biomed Res       Date:  2021-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.